Updated Date: Fri, 24 Apr 2020 00:00:00 EDT
Updated Date: Fri, 24 Apr 2020 00:00:00 EDT
Updated Date: Fri, 24 Apr 2020 00:00:00 EDT
Days after U.S. officials reported the first positive controlled data for Gilead’s remdesivir in COVID-19, the FDA has […]
There is never a good time for a pandemic, but covid-19 kicked doctors while we were down. Between […]
Doctors should reassure parents and carers of children who are immunocompromised that immunosuppression does not seem to increase […]
The only time that Denis Wirtz, vice provost for research at Johns Hopkins University in Baltimore, can find […]
AbbVie may be working through COVID-19, but it’s pressing ahead with its Allergan merger, too—and taking stock of products […]
Gilead Sciences scored a massive win earlier this week with its first positive data readout for investigational candidate […]
At the J.P. Morgan Healthcare Conference in January—back when few could predict the looming destruction of COVID-19—Amgen CEO […]